From: Lidocaine for systemic sclerosis: a double-blind randomized clinical trial
Group
Placebo
Lidocaine
P value
n
%
Frequency of adverse effects
No adverse effect
9
75,0%
6
50,0%
0,400 (F)
At least one effect
3
25,0%